Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

Acute Assessment of patients with proven or suspected COVID-19

Checked: 20-04-2021 by vicky.ryan Next Review: 19-04-2022

BNSSG - Remote assessment guidance

Please see the BNSSG Primary care assessment and management of Covid-19, and of all people (Covid and non-Covid) requiring admission (last updated 20.04.21).

The guideline can be used when making management decisions on patients with suspected or confirmed COVID-19. You also have the additional option of referring into the COVID Oximetry@Home service run by Sirona for patients who meet the criteria.

The guidelines advise use of the Charlson Comorbidity Index which may support clinical decision making when discussing appropriateness of admission with our patients.

There is also information in this guidance on:

  • COVID-19 in the community
  • Cardiopulmonary Resuscitation
  • Children and COVID-19
  • Assessing severity of COVID-19 on the telephone
  • Frailty  and comorbidities
  • When to consider antibiotics and antibiotic choice
  • Safety netting
  • Face to face assessment
  • Video consultations
  • Safeguarding, domestic violence and vulnerable people
  • Adults with COVID-19 and asthma
  • Adults with COVID-19 and COPD
  • End of life, death verification and certification 

Please also see NICE COVID-19 rapid guideline: managing COVID-19 (NG191) which make reference to assessments using the Clinical Frailty Score (CFS).These guidelines make it clear that ‘the CFS should not be used in younger people, people with stable long-term disabilities, for example cerebral palsy, learning disability or autism. 

Acute Assessment and Monitoring in Primary Care


See the COVID Oximetry@Home page.


Other resources:

NICE guidelines - COVID-19 rapid guideline: managing COVID-19 (NG191)

COVID-19: a remote assessment in primary care (25.3.20) - BMJ 10 minute consultation guide.

RECAP (Remote COVID-19 Assessment in Primary Care) project is a collaboration between the University of Oxford and Imperial College London with the aim of developing a tool to assist primary care providers in the identification of those COVID- 19 patients at risk of becoming severe, in order to facilitate the rapid escalation of their treatment and increase the chances of better outcomes.